For my first couple of years investing, I did this the slow way. I’d hear a company mentioned on a podcast, pull up its financials, decide it was too expensive, and start over. Weeks of effort, a handful of ideas. Then a friend sat me down in front of a screener, set three filters, and surfaced more credible candidates in ten seconds than I’d found in a month. I felt a little stupid. I also never went back.
So here’s the honest version up front. The best stock screeners are tools that filter thousands of companies down to a short list matching your exact criteria — revenue growth, earnings momentum, valuation, profitability — in seconds. For growth investors, the standouts are Finviz, Stock Rover, TradingView, and Zacks, and which one wins depends on whether you value speed, depth of data, or charting. No single screener is best for everyone, and I’ll tell you where each one shines and where it frustrates me.
A screener won’t pick stocks for you. What it does is hand you a manageable list of candidates worth a real look, so your research hours go toward analysis instead of digging. It’s the difference between fishing the whole ocean and fishing where the fish actually are. Let me walk you through the tools I’d recommend, what to filter on, and a starter template you can paste in today.
What separates the best stock screeners from the rest
Not every screener is built for what we do. A lot of them are tuned for day traders chasing momentum or value hunters looking for cheap balance sheets, and those filters don’t help much when you’re trying to isolate fast-growing companies. Before I compare specific tools, here’s what I actually look for under the hood.
Fundamental growth filters that go deep enough
This is the non-negotiable part. A screener has to let you filter on revenue growth year over year, EPS growth both quarterly and annual, and ideally earnings surprise history so you can find companies that keep beating estimates. If a tool can’t screen on growth rates with any precision, it’s useless to me no matter how slick it looks. These are the metrics that define a growth company, which is why I lean on them in my guide to How To Find Growth Stocks.
Valuation filters so you don’t overpay
Finding growth is only half the job. You also want growth at a price that isn’t insane, so the screener needs P/E (trailing and forward), the PEG ratio, and price-to-sales at a minimum. I use these to weed out names where the stock has detached from the business — where the company is wonderful but the multiple already assumes a decade of flawless execution. PEG in particular is my quick gut-check for whether a high P/E is justified by the growth behind it.
Quality metrics that separate real businesses from cash-burners
Growth without quality is how you end up holding a story stock that never turns a profit. The screeners I trust let me filter on return on equity, gross and operating margin, and debt-to-equity. These tell me whether I’m looking at a durable, improving business or a company torching cash with no clear path to making money. A glance at the balance sheet matters more than people think, and I get into the why in my piece on How to Analyze Growth Stock Balance Sheets.
Saving, exporting, and alerts
Screening isn’t a one-and-done event. The market moves, new companies cross your thresholds, old ones fall out, and you want to catch that. So I care whether a tool lets me save a custom screen, rerun it on a schedule, export results to a spreadsheet, and ideally fire an alert when a fresh name qualifies. The screens I run weekly are the ones that actually feed my watchlist over time.
The best stock screeners compared at a glance
Here’s the map I keep in my head. Each of these tools is genuinely good, but they’re good at different things, and the “right” one depends on how you work and what you’re willing to pay. Treat this table as a starting frame — pricing and feature tiers shift, so confirm the current details on each provider’s site before you commit.
| Screener | Best for | Free version? | Standout strength | Main limitation |
|---|---|---|---|---|
| Finviz | Fast, broad growth screening | Yes, very capable | Quick filtering plus a visual market heatmap | Delayed data; advanced features need Elite |
| Stock Rover | Deep fundamental research | Limited free tier | Huge library of metrics and historical depth | Steeper learning curve; best features are paid |
| TradingView | Screening plus charting | Yes | Best-in-class charts tied to the screener | Fundamental depth trails the dedicated tools |
| Zacks | Earnings-estimate-driven growth | Some free screens | Estimate revisions and its proprietary rank | Paywalls the strongest screens and data |
| Brokerage built-ins | Convenience inside your account | Yes, with your account | Free and already where you trade | Often clunkier and less flexible than the above |
Notice there’s no single winner. I personally bounce between two or three of these depending on the job — a quick Finviz pass to generate ideas, then something deeper to vet the survivors. Let me take the important ones one at a time.
Finviz: the one I’d start with
If you’re new to screening, start here. Finviz (short for Financial Visualizations) has been a favorite among growth investors for years, and the free version is honestly more capable than it has any right to be. You get dozens of filter criteria spanning fundamentals, technicals, and descriptive categories — enough to build a real growth screen without paying a cent.
What makes it click for me is the blend of breadth and speed. You can filter on EPS growth across several timeframes, sales growth, P/E, PEG, ROE, margins, and a long list of other inputs from one clean interface, and the results update instantly. The visual heatmap is a nice bonus — a quick way to see which sectors are running hot before you even start filtering. When I want ideas fast, Finviz is usually my first stop.
The catch with the free tier is that data runs delayed, and the genuinely advanced stuff — real-time quotes, backtesting, more screening slots — sits behind the Elite subscription. That runs roughly forty dollars a month last I checked, but pricing moves, so confirm the current cost. For pure idea generation, though, most growth investors never actually need to pay. The free version does the job.
Stock Rover: where I go to do the homework
Once Finviz hands me a short list, Stock Rover is often where I take the survivors apart. This is the research-heavy tool of the bunch, with a metrics library that’s genuinely deep — hundreds of data points, long historical ranges, and screening logic that lets you build something far more nuanced than a handful of filters. If you like to dig, you’ll feel at home here.
The trade-off is that all that depth comes with a learning curve, and the most useful features live in the paid tiers. The free version exists but it’s limited. Stock Rover isn’t the tool I’d hand a beginner on day one, but it’s the one I reach for to compare a name against its peers, study margin trends over years, or stress-test whether a growth story holds up. It rewards the kind of patient digging I describe in my walkthrough on How to Read Earnings Reports for Growth Stocks.
TradingView and Zacks: charts and estimates
These two earn their spots for different reasons, and I use them differently.
TradingView is the one I open when I want a chart while I screen. Its charting is about as good as it gets for a retail tool, and the screener sits right alongside it, so I can filter for growth names and immediately eyeball where a stock sits relative to its trend, its moving averages, its recent base. The fundamental depth doesn’t match a dedicated research tool, so I wouldn’t lean on it for heavy quality analysis. But for marrying a clean technical picture to a growth screen, it’s hard to beat, and the core version is free.
Zacks comes at growth from the earnings-estimate angle, which I find useful as a second lens. Its whole identity is built around analyst estimate revisions and a proprietary rank that tracks how estimates are trending — and rising estimates have historically been a tailwind for growth stocks. Some screens are free, but the strongest data sits behind a subscription, so price it out first. I treat the Zacks rank as one input among several, never a buy signal on its own. Estimate momentum is one of the cleanest reads on whether the market’s expectations for a company are improving, which ties into the broader idea of Revenue Growth Rate Analysis.
Don’t sleep on your broker’s free screener
Here’s something people overlook: the screener already sitting inside your brokerage account is free, and it’s better than it used to be. Fidelity, Schwab, and the others all bundle screening tools, and for a lot of investors that’s enough to get started — no extra logins, no subscriptions, and the results sit right next to your watchlist and your order ticket.
Are they as flexible as the dedicated tools? Usually not. The interfaces can be clunky, the filter sets thinner, the alerting more limited. But if you’re just getting going and don’t want yet another account, start with what your broker gives you before you pay for anything. You can always graduate to Finviz or Stock Rover later. The tool matters far less than the discipline of actually using it every week.
A growth screening template you can use today
People always ask me what to actually type into the boxes, so here’s a starting point. This isn’t a magic formula and it’ll need tuning to your own risk tolerance, but it’s a sane set of filters for surfacing quality growth candidates rather than speculative junk. Adjust the thresholds, see how many names survive, and loosen or tighten from there.
- Revenue growth: year-over-year sales growth above roughly 15 to 20 percent, to make sure the top line is genuinely expanding.
- EPS growth: positive and accelerating earnings growth, both quarterly and annual, so the profits are following the revenue.
- Profitability or a clear path to it: positive operating margin, or for younger names, margins that are visibly improving toward breakeven.
- Return on equity: ROE above the mid-teens as a rough quality screen, to favor businesses that compound capital efficiently.
- Valuation sanity check: a PEG ratio that isn’t wildly elevated, so you’re not paying any price for the growth.
- Balance sheet: manageable debt-to-equity, because growth funded by a mountain of borrowing is fragile when conditions tighten.
Run that, and you’ll typically get a list short enough to research one name at a time. From there the real work begins — reading the filings, understanding the business, judging the durability of the growth. The screen gets you to the doorstep; it doesn’t walk you through the house. That same process is how I build out something like my list of the Best Growth Stocks to Buy in 2026.
Mistakes I see people make with screeners
A screener is a power tool, and like any power tool it’ll hurt you if you’re careless. The first mistake is over-filtering — stacking so many criteria that you crush the list down to two names and miss everything interesting in between. I’d rather start loose and tighten than start so tight I never see the candidates worth a second look.
The second is treating the output as a buy list. It isn’t. Every name that survives a screen still has to clear your actual research, and plenty won’t once you read the story behind the numbers. A company can pass every quantitative filter and still be a bad business — declining product, a lawsuit, a competitor eating its lunch. The screen can’t see any of that.
The third is screening once and forgetting it. The whole point is repetition; the names that qualify shift as new earnings land, and the candidate I want might not have existed last quarter. And the last one: trusting stale data. Free tiers run delayed and figures move, so always verify the current numbers on a primary source before you act on anything a screener tells you.
Frequently asked questions
Are free stock screeners good enough for growth investing?
For most people, yes. Finviz’s free version, TradingView’s core tool, and the screener inside your brokerage account can all build a solid growth screen without costing anything. Paid tools like Stock Rover and Zacks add depth, historical data, and better alerts, which matter more as you get serious. I’d start free, learn what you actually need, then upgrade only if you hit a real ceiling.
What metrics should I screen for to find growth stocks?
I start with revenue growth and EPS growth to confirm the business is genuinely expanding, then layer on quality filters like return on equity and operating margin to weed out cash-burners. A valuation check such as the PEG ratio keeps me from overpaying. The exact thresholds depend on your risk tolerance, but that combination of growth, quality, and price is the core of any sensible growth screen.
Which is the best stock screener overall?
There isn’t one best answer, and anyone who says otherwise is selling something. For fast, broad idea generation I lean on Finviz. For deep fundamental research I prefer Stock Rover. For charting alongside screening, TradingView wins, and for earnings-estimate momentum, Zacks. I use several depending on the task. Pick the one that matches how you work, and confirm current pricing before you subscribe to anything.
How often should I run my stock screens?
I rerun my core screens weekly or monthly, because the companies that qualify change as new earnings land and fundamentals shift. Screening is an ongoing prospecting habit, not a one-time search — the candidate you want next quarter might not pass today. Saving your screens and setting alerts where the tool allows makes this painless, so fresh names land on your watchlist without you starting from scratch each time.
Can a stock screener tell me what to buy?
No, and treating it that way is how people get burned. A screener gives you a short list of candidates that match your numerical criteria, nothing more. Each name still has to clear real research — the business model, the competition, the durability of the growth, the things numbers can’t show. Use the screen to decide what’s worth studying, then do the actual homework before you buy anything.
The Bottom Line
The best stock screeners won’t make you a better investor on their own, but they’ll hand back the hours you’d otherwise waste hunting for ideas, and that’s worth a lot. My honest advice: start with a free tool — Finviz, TradingView, or whatever your broker already gives you — build a simple growth screen around revenue growth, earnings momentum, quality, and a valuation check, and run it on a schedule. Treat the output as a list of things to research, never a list of things to buy. Get that habit going, stay disciplined about price, and the screener quietly becomes one of the most valuable tools in your whole process.
Last updated: June 2026. Figures are approximate and change — confirm current data before investing. Educational only, not individual investment advice.
